10A NCAC 42B .0107      Newborn screening for pompe disease, mps-1, and x-ald

Pompe disease, Mucopolysaccharidosis Type I (MPS I), and X-Linked Adrenoleukodystrophy (X-ALD) are added to the Newborn Screening Program. The process to develop and implement new tests for these conditions shall begin after the fee is established and adequate funds exist to acquire instrumentation, equipment, Program supplies, Program personnel, perform assay validations, implement preventative follow-up interventions, secure necessary infrastructure, and with the assurance that the laboratory has met all federal, State, and local requirements.

History Note:        Authority G.S. 130A‑125;

Eff. September 1, 2018.